109 related articles for article (PubMed ID: 22050317)
1. Migraine attack frequency, duration, and pain intensity: disease burden derived from a community-based survey in northern Tanzania.
Dent W; Stelzhammer B; Meindl M; Matuja WB; Schmutzhard E; Winkler AS
Headache; 2011; 51(10):1483-92. PubMed ID: 22050317
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of migraine headache in a rural area of northern Tanzania: a community-based door-to-door survey.
Winkler AS; Dent W; Stelzhammer B; Kerschbaumsteiner K; Meindl M; Kaaya J; Matuja WB; Schmutzhard E
Cephalalgia; 2010 May; 30(5):582-92. PubMed ID: 19735479
[TBL] [Abstract][Full Text] [Related]
3. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
4. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of migraine in a rural area in South Tanzania: a door-to-door survey.
Dent W; Spiss H; Helbok R; Matuja W; Scheunemann S; Schmutzhard E
Cephalalgia; 2004 Nov; 24(11):960-6. PubMed ID: 15482359
[TBL] [Abstract][Full Text] [Related]
7. The occipital alpha rhythm related to the "migraine cycle" and headache burden: a blinded, controlled longitudinal study.
Bjørk MH; Stovner LJ; Nilsen BM; Stjern M; Hagen K; Sand T
Clin Neurophysiol; 2009 Mar; 120(3):464-71. PubMed ID: 19157973
[TBL] [Abstract][Full Text] [Related]
8. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
9. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration.
Stewart WF; Shechter A; Lipton RB
Neurology; 1994 Jun; 44(6 Suppl 4):S24-39. PubMed ID: 8008223
[TBL] [Abstract][Full Text] [Related]
10. The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics.
Payne KA; Varon SF; Kawata AK; Yeomans K; Wilcox TK; Manack A; Buse DC; Lipton RB; Goadsby PJ; Blumenfeld AM
Cephalalgia; 2011 Jul; 31(10):1116-30. PubMed ID: 21690175
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
12. Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.
Linde M; Dahlöf C
Cephalalgia; 2004 Jun; 24(6):455-65. PubMed ID: 15154855
[TBL] [Abstract][Full Text] [Related]
13. [Migraine: clinical features and disability in a rural population in Cuba].
Quesada-Vazquez AJ; Contreras-Maure LJ; Traba-Tamayo ER; Frometa-Guerra A
Rev Neurol; 2010 Jan 16-31; 50(2):72-6. PubMed ID: 20112214
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
[TBL] [Abstract][Full Text] [Related]
16. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
17. The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey.
Zebenigus M; Tekle-Haimanot R; Worku DK; Thomas H; Steiner TJ
J Headache Pain; 2017 Dec; 18(1):58. PubMed ID: 28547735
[TBL] [Abstract][Full Text] [Related]
18. Direct cost burden among insured US employees with migraine.
Hawkins K; Wang S; Rupnow M
Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
[TBL] [Abstract][Full Text] [Related]
19. Migraine days decline with duration of illness in adolescents with transformed migraine.
Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the burden of migraine using the willingness to pay model.
Hamelsky SW; Lipton RB; Stewart WF
Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
